Solicitor's certificate of service on behalf of Kiernan A. Murphy confirming service of Doc. #47 upon Respondents by email and telecopier on 31-MAY-2013 filed on 31-MAY-2013

Covering letter from Applicants dated 31-MAY-2013 concerning Doc. No. 47 placed on file on 31-MAY-2013

Discontinuance on behalf of Applicants filed on 31-MAY-2013

Written directions received from the Court: The Honourable Mr. Justice O'Reilly dated 31-MAY-2013 directing that "The Court is prepared to hear the parties today, May 31, 2013 at 10:00 a.m. Teleconference approximate duration of 1 hour. Counsel can remain in Chambers." placed on file on 31-MAY-2013 Confirmed in writing to the party(ies)

Letter from Respondent - Apotex Inc. dated 30-MAY-2013 "...we request an urgent case conference with Justice O'Reilly to discuss the implications of the decision and the impact it may hve on our hearing scheduled next week. The parties are available tomorrow, Friday, May 31, 2013 at anytime between 10am and 12pm to participate in the case conference" received on 30-MAY-2013

Written directions received from the Court: The Honourable Mr. Justice O'Reilly dated 29-MAY-2013 directing that "Please ensure that the parties in T-1640-11 receive a copy of my judgment in T-1044-11 rendered today." placed on file on 29-MAY-2013 Confirmed in writing to the party(ies)

Affidavit of service of Mirella Ricci sworn on 15-APR-2013 on behalf of respondent, Apotex Inc. confirming service of Doc. No. 45 and Books of Authorities upon Applicant and respondent Minister of Health by courier on 15-APR-2013 filed on 15-APR-2013

Book of Authorities consisting of 2 volume(s) on behalf of respondent, Apotex Inc. received on 15-APR-2013

Sealed envelope pursuant to order dated 21-MAR-2012 on behalf of respondent, Apotex Inc. purporting to contain the respondent's application record Filed on 15-APR-2013

Covering letter from Applicant dated 15-MAR-2013 concerning Doc. Nos. 42 43 44 placed on file on 15-MAR-2013

Solicitor's certificate of service on behalf of Kiernan A. Murphy confirming service of 42 43 upon Respondent by personal service on 15-MAR-2013 filed on 15-MAR-2013

Book of Authorities consisting of 2 volume(s) on behalf of Applicant received on 15-MAR-2013

PUBLIC VERSION - Application Record (4 volumes) Number of copies received/prepared: 3 on behalf of Applicant filed on 15-MAR-2013

CONFIDENTIAL VERSION - Application Record (4 volumes) Number of copies received/prepared: 3 on behalf of Applicant filed on 15-MAR-2013

Acknowledgment of Receipt received from all parties by email 5-MAR-13 with respect to Doc.41 placed on file on 05-MAR-2013

ORDER(Re:CONFIDENTIALITY of Apotex's 'ANDS' and 'DMF') dated 05-MAR-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Apotex dated 26-FEB-2013 re: seeking a Confidentiality Order designating certain materials as being "confidential", as defined in paragraph 5 of the Protective Order. Result: granted 1....2. Wherever a party seeks to file in this Court documents or portions thereof, including affidavits, exhibits, transcripts or motion materials, which contain or discuss in a manner that would disclose its content, the confidential information defined in paragraph 1 of this Order("Confidential Information"), the Confidential Information shall be segregated from other information and documentation being submitted for filing and shall be submitted to the Court in sealed envelopes indentifying this proceeding and permanently marked with the following: **SEE ORDER FOR DETAILS Filed on 05-MAR-2013 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1186 page(s) 7 - 9 Interlocutory Decision

Communication to the Court from the Registry dated 28-FEB-2013 re: Apotex's letter dated February 26, 2013

Memorandum to file from C. Clement dated 28-FEB-2013 I contacted counsel for Apotex regarding their letter dated February 26, and specifically the attached Order dated January 24, 2013. Counsel for Apotex have confirmed that they inadvertently attached to their letter the scheduling Order of January 24th, rather than the protective Order dated the same day. A copy of the Protective Order dated January 24th will be brought to the Court's attention in conjunction with Apotex's letter. placed on file.

Letter from Apotex Inc. dated 26-FEB-2013 "...Pursuant to, and in accordance with, the Protective Order, Apotex designated documents produced by it pursuant to ss 6(7) of the Regulations as being Confidential Information...Paragraph 10 of the Protective Order provides that, in the event a party intends to file the Confidential Information of another party, notice shall be given to the designating party such that an opportunity exists to seek and obtain a Rule 151 Order...On February 19, 2013, counsel for the applicants provided notice to Apotex of its intention to file, as part of its application record, those documents that Apotex has produced....As such, we are writing to respectfully request that an order or direction issue pursuant to Rule 151 allowing both parties to file as confidential in sealed envelopes those portions of documents which disclose: (See letter for details) We have conferred with the applicants' counsel and can advise that they consent to the order or direction sought herein. Should the Court wish that a formal motion be brought, we will attend to doing so forthwith." received on 26-FEB-2013

****** CANCELLED ****** Letter from Applicant dated 14-FEB-2013 seeking Directions of the CMJ re: filing of Joint Application Record received on 14-FEB-2013

Ottawa 15-FEB-2013 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: No Direction will issue. held in chambers by way of Conference Call Duration per day: 15-FEB-2013 from 12:00 to 12:20 Courtroom : Judge's Chambers - Ottawa Court Registrar: Alison Dickenson Total Duration: 20 minutes Appearances: Christopher Van Barr and Kiernan Murphy (613) 786-8675 representing Applicant Andrew Brodkin (416) 597-4278 representing Respondent Apotex Inc. * no one appearing * representing Respondent Minister of Health Comments: The parties discussed the issues; the Court will not intervene at this time. Minutes of Hearing entered in Vol. 875 page(s) 447 - 449 Abstract of Hearing placed on file

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 15-FEB-2013 directing that "A case management telephone conference will be held at 12 (noon) on 15-FEB-2013." placed on file on 15-FEB-2013 Confirmed in writing to the party(ies)

Letter from Applicant dated 14-FEB-2013 requesting a case management conference at the Court's earliest convenience to address new DMF productions provided by Apotex. In particular, the Applicants will seek a new schedule and the opportunity to file an amended Notice of Application...We have contacted Apotex's counsel...and can advise that counsel are both available on the afternoon of Friday, Feb. 15, 2013. **Note attached correspondence (scanned to CMJ) received on 14-FEB-2013

Acknowledgment of Receipt received from all parties via email on Nov. 21 with respect to Doc.40 placed on file on 22-NOV-2012

Order dated 20-NOV-2012 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Respondent dated 08-NOV-2012 re: extending deadlines in the July 20, 2012 Scheduling Order Result: 1. Cross-examinations on affidavits shall be completed by Feb. 1, 2013. 2. Applicant's application record shall be served & filed by March 15, 2013. 3. Respondent's application record shall be served & filed by April 15, 2013 Filed on 21-NOV-2012 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1175 page(s) 205 - 206 Interlocutory Decision

Communication to the Court from the Registry dated 13-NOV-2012 re: Apotex's letter seeking extensions of time to the scheduling Order of July 20, 2012.

Memorandum to file from C. Clement dated 07-NOV-2012 I contacted counsel for Apotex regarding their letter dated November 2, 2012 as counsel for the Minister and for the Applicant were not copied. Ms. Anderson, counsel for Apotex, will submit a fresh letter with a copy to all parties. placed on file.

Letter from Respondent (Apotex) dated 08-NOV-2012 seeking extensions of time of the July 20, 2012 scheduling Order. (Note: This letter is identical to that of November 2, 2012, however, the Applicant and the Minister were copied on this version) received on 08-NOV-2012

Communication to the Court from the Registry dated 06-NOV-2012 re: R's letter dated 2-NOV-2012 (sent to Tabib P. c/o Ottawa CMT)

Letter from Respondent, Apotex dated 02-NOV-2012 on behalf of the parties, to seek additional time to complete cross- examiantions (cc'd to A's counsel) received on 02-NOV-2012

Acknowledgment of Receipt received from all parties with respect to Order (time and place)(Doc. No. 39). placed on file on 09-OCT-2012

Order (time and place) dated 09-OCT-2012 rendered by Chief Justice Crampton and signed by Judicial Administrator fixing Judicial Review (s.18) to be heard at Special Sitting in Ottawa on 03-JUN-2013 to begin at 09:30 duration: 4d language: E Filed on 09-OCT-2012 cc's sent to parties entered in J. & O. Book, volume 1170 page(s) 82 - 82 Transmittal letters placed on file

Communication to the Court from the Registry dated 03-OCT-2012 re: Requisition for Hearing filed October 1, 2012 sent to Judicial Administrator

Covering letter from Applicant dated 01-OCT-2012 concerning Doc. No. 37 placed on file on 02-OCT-2012

Solicitor's certificate of service on behalf of Kiernan A. Murphy confirming service of Doc. 37 upon Respondent by telecopier on 01-OCT-2012 filed on 01-OCT-2012

Requisition for hearing - Application from Applicant filed on 01-OCT-2012 Tariff Application or appeal - $50.00

Solicitor's certificate of service on behalf of Kiernan A. Murphy confirming service of Affidavit of Dr. Mark Lautens sworn on September 21, 2012 upon Respondents by personal service on 21-SEP-2012 filed on 21-SEP-2012

Confirmation of receipt received from Applicant with respect to confidential 4th volume submitted with Motion Record Doc. 34: 3 copies returned to counsel in accordance with paragraph 1 of Order Doc. 28 picked up at Ottawa Counter by Gowlings on 20-JUL-2012 placed on file on 20-AUG-2012

Acknowledgment of Receipt received from all parties with respect to Order Doc. 28 by E-MAIL placed on file on 20-JUL-2012

Covering letter from Applicant dated 12-JUL-2012 concerning enclosed Motion Record in support of Motion Doc. 22: 4 volumes are submitted; 2 of which are confidential. NOTE: 4th volume returned to counsel pursuant to paragraph 1 of the Order (Doc. 28) dated 20-JUL-2012. Motion Record Doc. 34 consists of public volumes 1 & 2 and confidential volume 3. placed on file on 12-JUL-2012

Solicitor's certificate of service on behalf of Tushar Tangri confirming service of Motion Record Doc. 34 plus 4th Volume (4th Volume returned by the Registry pursuant to para. 1 of the Order (Doc. 28) dated 20-JUL-2012) upon all parties by courier on 12-JUL-2012 filed on 12-JUL-2012

Motion Record (3 Volumes- Vol. 3 is Confidential) Number of copies received/prepared: 3 containing the following original document(s): 29 30 31 32 33 on behalf of Applicant filed on 12-JUL-2012 Document placed in Annexes C VA Y1

Sealed envelope pursuant to Order dated 21-MAR-2012 on behalf of Applicant purporting to contain Confidential Written Representations in support of Motion Doc. No. 22 Filed on 12-JUL-2012

Transcript of cross-examination held on 03-JUL-2012 RE: Affidavit of Kevin Zive sworn on 21-JUN-2012 filed on 12-JUL-2012

Affidavit of Kevin Zive sworn on 21-JUN-2012 contained within a Motion Record on behalf of Respondent in opposition to Motion Doc. No. 22 with Exhibits 1 through 51 filed on 12-JUL-2012

Transcript of cross-examination held on 05-JUL-2012 RE: Affidavit of Susan Burkhardt sworn on 8-JUN-2012 filed on 12-JUL-2012

Affidavit of Susan Burkhardt sworn on 08-JUN-2012 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 22 with Exhibits "A" through "F" filed on 12-JUL-2012

Order dated 20-JUL-2012 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 22 Result: 1. The Applicant's motion is withdrawn without costs to either party and the records, submitted for filing under seal without a confidentiality order, are to be returned to the parties; 2. The scheduling of this proceeding shall continue as follows with amendment as necessary to the scheduling Order of January 24, 2012: a) The Applicants shall serve their evidence on infringement and the Respondent(Apotex) shall serve its evidence on invaladity no later than August 3, 2012, and both the Applicants and the Respondent shall dispense with the filing of evidence with the Court until the filing of their respective Application Records; b)The Applicants shall serve their evidence on invalalidity and the Respondent (Apotex) shall serve its evidence on infringement no later than September 21, 2012 of receiving the Respondent's evidence on validity and the Applicants' evidence on infringement, respectively, and both the Applicants and the Respondent shall dispense with the filing of evidence with the Court until the filing of their respective Application Records; c)Cross-examinations on affidavits shall be completed no later than November 28, 2012; d)The Applicants' application record shall be served and filed by January 29, 2013; e) The Respondent's responding application record shall be served and filed by February 28, 2013; f)This schedule is without prejudice to either party's right to seek and extension if the requesting party requires additional time. g)Parties shall keep themselves available for a 4 day hearing of this matter beginning June 3, 2013. h) A requisition for hearing is to be filed no earlier than September 21, 2012 and no later than October 1, 2012, requesting dates beginning on June 3, 2013, unless it otherwise appears that the parties will not be ready to proceed on that day, or the Court directs otherwise. The Court's decision is with regard to Letter from Applicant dated 18-JUL-2012 re: Draft Order concerning motion Doc.22 and scheduling Order Result: See above for details Filed on 20-JUL-2012 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1163 page(s) 396 - 398 Interlocutory Decision

Ottawa 19-JUL-2012 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to discuss the draft consent order submitted by parties regarding Motion Doc. 22 which was previously scheduled to be heard on July 17, 2012. The Court will also address the filing of the Applicant's moving motion records (received only) containing confidential materials which cannot be filed under seal, as indicated at par. 10 of the Amended As Fresh Protective Order. Result of Hearing: The Court will issue the parties draft order tomorrow. Parties have agreed to make themselves available to have this application heard in the months following the hearing in T-1044-11 (JR scheduled for March 18, 2013). The Court will allow the applicant's moving records to be filed, with the confidential portion being returned to counsel. held in chambers by way of Conference Call Duration per day: 19-JUL-2012 from 03:35 to 04:15 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 40min Appearances: Christopher Van Barr/Kiernan Murphy 613-786-8675 representing Applicant Andrew Brodkin/David Lederman 416-597-4278 representing Respondent Minutes of Hearing entered in Vol. 865 page(s) 435 - 442 Abstract of Hearing placed on file

Letter from Applicant dated 19-JUL-2012 in response to Apotex's letter sent this morning. In its letter, Apotex refers to the proceeding in T-1044-11 (the "Cobalt proceeding"). Two issues are raised by Apotex's correspondence...(see letter for details) Regarding the Requisition for Hearing, Bayer submits that it is simply premature to file at this time...With respect to Apotex's submission that its proceeding should be heard at the same time or following the Cobalt proceeding, Bayer submits that a concurrent proceeding would cause significant procedural difficulties...(scanned) received on 19-JUL-2012

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 19-JUL-2012 directing that "The case management telephone conference is adjourned from 11:00a.m. to 3:30p.m. today." placed on file on 19-JUL-2012 Confirmed in writing to the party(ies)

Letter from Applicant dated 19-JUL-2012 (by email)in response to the letter and decision sent by counsel for Apotex 1/2 hour before the scheduled case conference....We do not have sufficient time to review and respond to these representations, nor to address the 112 page decision Apotex has just provided...In view of the above, we request an adjournment of today's conference call so that we may prepare and respond to these late submissions... received on 19-JUL-2012

Letter from Respondent dated 19-JUL-2012 "We write in anticipation of the short case management conference scheduled to take place at 11:00a.m. this morning and to provide some context as to the revised timetable of next steps set out in the draft order submitted by the Applicants yesterday and why Apotex requested today's case conference to take place. Recently, Apotex became aware of a hearing date scheduled in T-1044-11(the "Cobalt" proceeding)...relating to the same drug product that is in issue herein. Specifically, the Cobalt Proceeding has been scheduled to be heard on the mertis for 4 days commencing on March 13, 2013...For the reasons provided below, Apotex respectfully submits that it would be in the interests of justice to ensure that this proceeding involving the same Applicants, the same patent and the same drug substance be scheduled to be heard at the same time, or immediately following the hearing in the Cobalt Proceeding, before the same Judge. (See letter for further details) **Reasons for Judgment and Judgment(Hughes, J.) rendered in T-1560-10 on June 18, 2012 is enclosed (112pgs). The full document has been placed in the annex, with a copy of the letter on the main file. (scanned) received on 19-JUL-2012

Letter from Applicant dated 18-JUL-2012 (by email) attaching the draft order concerning the motion for production (Doc.22)-scanned received on 18-JUL-2012

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 18-JUL-2012 directing that "A short case management telephone conference will take place on Thursday, July 19, 2012 at 11:00a.m." placed on file on 18-JUL-2012 Confirmed in writing to the party(ies)

Letter from Respondent dated 18-JUL-2012 (by email)"The parties have settled the terms of the draft Order. We expect that counsel for Bayer will submit the draft Order later today. Apotex still requests a short case conference to discuss case management issues. The parties are available for such a call between 10a.m. and 11:30a.m. tomorrow, July 19. Please let us know if Madam Prothonotary Tabib can accomodate this request..." (scanned) received on 18-JUL-2012

Memorandum to file from Case Management Team(OTT) dated 17-JUL-2012 Upon speaking with counsel for the Respondent regarding Mr. Brodkin's unavailability for the case conference today at 11:45, as well as discussing this matter with counsel for the applicant, the Court has determined that a new date for a case managment teleconference will be scheduled if necessary, once completion of the terms of the draft order have been done. Parties have agreed to advise the Registry once the draft order has been agreed upon, and whether or not a case conference is still required. The Court has also been advised of the applicant's letter by email dated July 17, 2012. placed on file.

Letter from Applicant dated 17-JUL-2012 "...we confirm our request that the Court return all confidential portions of the Applicant's motion record to the undersigned. Regarding the case managment conference scheduled for today, we confirm the parties are still discussing the terms of the draft order. Accordingly, we believe the conference is premature. Provided the arties agree on the terms of the order, as we expect will be the case, we believe the conference will not be required at all. We will provide a copy of the draft order as soon as possible. If, at that time, the parties believe a case conference is necessary, we will be pleased to advise and will provide joint proposed dates." received on 17-JUL-2012

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 17-JUL-2012 directing that "A short case management teleconference will take place at 11:45 today." placed on file on 17-JUL-2012 Confirmed in writing to the party(ies)

****** CANCELLED ****** Oral directions received from the Court: Mireille Tabib, Prothonotary dated 18-JUL-2012 directing that "A short case management telephone conference will take place on Thursday, July 19, 2012 at 11:00a.m." placed on file on 18-JUL-2012 Confirmed in writing to the party(ies)

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 16-JUL-2012 directing that The Applicant's motion (Doc.22) for 6(7) Production and Verification and for an Extension of time to serve evidence, scheduled to be heard at a special sitting on July 17, 2012 at 9:30a.m., is now cancelled. placed on file on 16-JUL-2012 Confirmed in writing to the party(ies)

Letter from Applicants (by email) dated 16-JUL-2012 advising the Court that counsel for Bayer and Apotex have reached a resolution to the motion being heard July 17, 2012. The parties are presently confirming the language of a draft order for the Court's consideration. If the Court wishes, counsel for Bayer and Apotex would be pleased to discuss the order with the Court tomorrow, preferably at 11:45a.m by teleconference or in person, as the Court prefers.(scanned) received on 16-JUL-2012

Solicitor's certificate of service on behalf of David E. Lederman confirming service of Doc 26 upon all parties by personal service on 13-JUL-2012 filed on 13-JUL-2012

Motion Record in response to Motion Doc. No. 22 containing the following original document(s): 24 25 Number of copies received: 3 on behalf of Apotex Inc., Respondent filed on 13-JUL-2012

Sealed envelope pursuant to Order dated 21-MAR-2012 on behalf of Apotex Inc., Respondent purporting to contain Written Respresentation of Apotex Inc dated 13-JUL-2012 Filed on 13-JUL-2012

Sealed envelope pursuant to Order dated 21-MAR-2012 on behalf of Apotex Inc., Respondent purporting to contain Cross examination transcript of Carrie Ku held 04-JUL-2012 Filed on 13-JUL-2012

Communication to the Court from the Registry dated 13-JUL-2012 re: Applicant's Motion Record RECEIVED on July 12, 2012 which is being heard in Ottawa on July 17, 2012. Parties are seeking leave to file confidential materials in their 6(7) motion records without the need to file a motion record as per paragraph 10 of the "Fresh As Amended Protective Order" dated March 21, 2012.

Memorandum to file from TORONTO dated 12-JUL-2012 JULY 11/2012 LETTER FOR DIRECTION FROM APOTEX INC., SCANNED TO CMT OTT AND C.CLEMENT FOR THE UPCOMING MOTION BEING HEARD JULY 17,2012. placed on file.

Letter from RESPONDENT-APOTEX INC. dated 11-JUL-2012 IN RESPECT OF APPLICANTS' MOTION (DOC 22) BEING HEARD JULY 17/2012; SEEKING COURT'S DIRECTION ON FILING OF MOTION MATERIALS ON BEHALF OF ALL PARTIES PURSUANT TO THE TERMS OF FRESH AS AMENDED PROTECTIVE ORDER DATED MARCH 21/12 received on 11-JUL-2012

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 20-JUN-2012 directing that "The Applicants' Motion (Doc. 22) pursuant to s. 6(7) of the Regulations may be made returnable at a Special Sitting in Ottawa beginning at 9:30 a.m. on 17-JUL-2012, for a duration not exceeding 2 hours." placed on file on 20-JUN-2012 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 15-JUN-2012 re: Notice of Motion dated June 8th seeking a special sitting in Ottawa on July 17, 2012 to hear the Applicant's 6(7) PM(NOC) motion for production.

Letter from Applicant dated 14-JUN-2012 We write to correct a clerical error in the Notice of Motion dated June 8, 2012. The Notice of Motion refers to the motion taking place in Toronto. It is the moving parties' request that the motion take place in Ottawa. received on 14-JUN-2012

Covering letter from the Applicants dated 08-JUN-2012 concerning Doc. Nos. 22 23 placed on file on 08-JUN-2012

Solicitor's certificate of service on behalf of Tushar Tangri confirming service of Notice of Motion doc # 22 upon the Respondents by courrier on 08-JUN-2012 filed on 08-JUN-2012

Notice of Motion on behalf of the Applicants returnable (but no hearing date indicated at this time) for 1. An Order pursuant to S.6.7 of the Patented Medicines (Notice of Compliance) Regulations requiring the Respondent Apotex inc. ("Apotex") to produce de following withing 10 days of the Order or to provide evidence of why is not able to do so: and other relief sought (...) filed on 08-JUN-2012

Letter from Applicant dated 04-JUN-2012 advisig the Court that the Applicant intends to bring a motion for further disclosure and for an extension of the date for serving evidence provided in the scheduling Order of January 24, 2012..At present we write to advise that counsel for Bayer and Apotex are available for a motion on July 10, 17 and 19 in the above-noted motion. Counsel expect the motion will take 2 hours. received on 04-JUN-2012

AMENDED AS FRESH PROTECTIVE ORDER dated 21-MAR-2012 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Respondent Apotex Inc. dated 12-MAR-2012 Result: granted Filed on 21-MAR-2012 copies sent to parties entered in J. & O. Book, volume 1152 page(s) 176 - 185 Interlocutory Decision

Communication to the Court from the Registry dated 15-MAR-2012 re: Apotex's letters dated February 23 and March 12 regarding parties joint request for amended protective order to be issued.

Letter from Respondent - Apotex Inc. dated 12-MAR-2012 "...The parties have now agreed to a form revised proposed Protective Order. A copy of the draft Order is attached to this letter. The parties jointly request the amendments to the Protective Order be permitted without the need for a formal motion..." attached copy of "Amended as Fresh Protective Order" received on 12-MAR-2012

Letter from Apotex Inc. dated 23-FEB-2012 to be directed to Prothonotary Tabib regarding the production of certain information from its supplier pursuant to the Order dated 24-JAN-2012 received on 23-FEB-2012

Affidavit of service of Johanna Palacios sworn on 30-JAN-2012 on behalf of Respondent confirming service of doc 19 upon Applicant Respondent by telecopier on 30-JAN-2012 filed on 30-JAN-2012

Notice of change of solicitor on behalf of Respondent filed on 30-JAN-2012

Acknowledgment of Receipt received from All parties with respect to Docs. #17 & #18 (Orders from Tabib, P. dated January 24, 2012). placed on file on 24-JAN-2012

Order dated 24-JAN-2012 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion Doc. No. 11 Result: 1. The within Application shall proceed according to the following schedule: (a) The Applicants shall serve their evidence on infringement and the Respondent (Apotex) shall serve its evidence on invalidity within 100 days of receiving Apotex's production pursuant to paragraphs 2(a) and 2(b) of this Order, provided such information is adequate for the purpose of assessing infringement, and both the Applicants and the Respondent (Apotex) shall dispense with the filing of evidence with the Court until the filing of their respective Application Records; (b) The deadline for serving the evidence referred to in paragraph 1(a) above shall be computed from the later date of production by Apotex pursuant to paragraphs 2(a) or 2(b), unless such deadline is amended pursuant to paragraph 1(c), or otherwise, herein; (c) If information produced by the Respondent (Apotex) is inadequate for the purpose of assessing infringement, the Applicants may move for further production and move for an amendment of this schedule extending the deadlines set out herein; (d) The Applicants shall serve their evidence on invalidity and the Respondent (Apotex) shall serve its evidence on infringement within 2 months of receiving the Respondent's evidence on validity and the Applicants' evidence on infringement, respectively, and both the Applicants and the Respondent (Apotex) shall dispense with the filing of evidence with the Court until the filing of their respective Application Records; (e) Within 15 days of receiving the Respondent's (Apotex) evidence on infringement, the Applicants shall request a case conference to discuss the scheduling of a hearing and setting a schedule for further steps to be taken in this application; and (f) Cross-examinations on affidavits shall be completed within 120 days of the Applicants serving their evidence on invalidity and the Respondent (Apotex) serving its evidence on infringement; 2. Pursuant to s.6(7)(a) of the Patented Medicines (Notice of Compliance) Regulations, Apotex shall: (a) produce the following within 15 days of the Order or provide evidence of why it is not able to do so: (i) the relevant portions of Apotex's Abbreviated New Drug Submission ("ANDS") in connection with orally administered tablets containing 3 mg drospirenone / 0.03 mg ethinyl estradiol, and in particular: (1) any portions showing the details of the process used in the formation of the bulk active ingredient used in Apotex's product; (2) any portions showing the character and composition of Apotex's bulk active ingredient drospirenone and, in particular, its purity; and (3) any portions detailing the compounds produced at the various stages of the process used in the formation of Apotex's bulk active ingredient drospirenone, including the presence, identity and percentage of impurities produced during this process; (ii) the following documents: (1) ANDS Module ¿ Manufacturer(s) (Drospirenone, Drug Substance); (2) ANDS Module ¿ Description of the Manufacturing Process and Process Controls (Drospirenone Drug Substance); (3) ANDS Module ¿ Impurities (Drospirenone, Drug Substance); and (4) ANDS Module ¿ Specifications (Drospirenone, Drug Substance); (b) use its best reasonable efforts to obtain and produce the following information within 30 days of the Order or provide evidence of why it is not able to do so: (i) the relevant portions of the drug master files ("DMF") incorporated by reference into Apotex's ANDS, and in particular: (1) any portions showing the details of the process used in the formation of the bulk active ingredient used in Apotex's product; (2) any portions showing the character and composition of Apotex's bulk active ingredient drospirenone and, in particular, its purity; and (3) any portions detailing the compounds produced at the various stages o

PROTECTIVE ORDER dated 24-JAN-2012 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 23-JAN-2012 re: Draft Protective on Consent in support of their motion doc.11 Result: granted Filed on 24-JAN-2012 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1146 page(s) 326 - 335 Interlocutory Decision

Communication to the Court from the Registry dated 23-JAN-2012 re: Applicant's draft scheduling order (received Jan.20/12) and protective order (received Jan.23/12) on consent of all parties

Letter from Applicant dated 23-JAN-2012 on consent of all Respondents, seek a Protective Order for this proceeding. (Consent and draft order are enclosed) received on 23-JAN-2012

Letter from Applicant dated 20-JAN-2012 The Applicants, with the consent of all Respondents, seek an order for a schedule for the parties' evidence, production of certain documents by the Respondent (Apotex) and verification thereof by the Respondent (Minister of Health). A draft order and the consent of all parties are attached. received on 20-JAN-2012

Ottawa 19-DEC-2011 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to discuss the Applicant's motion and any outstanding issues remaining from the motion that have not yet been settled. Result of Hearing: Counsel are to provide the Court with a consent draft order regarding the Applicant's motion held in chambers by way of Conference Call Duration per day: 19-DEC-2011 from 11:00 to 11:15 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 15min Appearances: Christopher Van Barr 613-786-8675 representing Applicant Kevin Zive 416-401-7992 representing Respondent Minutes of Hearing entered in Vol. 854 page(s) 370 - 372 Abstract of Hearing placed on file

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 15-DEC-2011 directing that A case management telephone conference will be held at 11am on December 19, 2011. placed on file on 16-DEC-2011 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 15-DEC-2011 re: Applicant and Respondent's letters dated December 14th, 2011 with attached draft scheduling and protective orders; CMC requested.

Memorandum to file from the case management team, Ottawa dated 15-NOV-2011 I contacted counsel to advise that the Applicants motion was not brought to my attention prior to the issuance of the Direction dated November 14th due to a backlog in the Registry. Counsel for the Applicants, Mr. Van Barr, advised that the parties were in dicussions regarding the motion and that motion may be settled entirely. The parties would be in contact with the Court by December 14th to address the Court's direction. placed on file.

Letter from Respondent dated 14-DEC-2011 is response to the direction dated November 14th and further to the letter of the Applicants that was sent to the Court today....we have agreed on a draft protective order and a proposed scheduling order. The remaining issue revolves around the issue of production pursuant to s.6(7) of the PMNOC Regulations. With respect to the issue of production, Apotex respectfully suggests the following wording for the Order: (see letter for details) The reason for our proposed wording is that the Drug Master File is owned by a third party supplier. The wording requested by the Applicants would require Apotex to produce documents that it does not have in its posession, power or control. received on 15-DEC-2011

Letter from Applicant dated 14-DEC-2011 filed in accordance with Prothonotary Tabib's Direction dated November 14, 2011 and is further to Bayer's Motion...the parties have agreed to most items requested in Bayer's motion and as listed in the Court's direction. Bayer submits that the remaining issues would benefit from a case management teleconference. We respond to the Court's direction in accordance with the paragraphs therein: (see letter for details)...the parties are jointly available for a case conference call on December 19 after 11:00am, 21 and 22 (Draft Orders re: Bayer's motion and a Protective Order attached) received on 14-DEC-2011

Letter from Applicant dated 14-NOV-2011 On November 10, 2011 the Applicants filed a Motion Record for a schedule, protective order, s.6(7) production, and verification. The parties are currently discussing the terms of the proposed orders. We will provide the Court with an update as soon as possible. received on 14-NOV-2011

Written directions received from the Court: Mireille Tabib, Prothonotary dated 14-NOV-2011 directing that The parties shall, no later than December 14, 2011, either jointly or seperately, file written submissions as to the following matters and issues: a)whether any motions pursuant to s. 6(7) of the PM(NOC) Regs. is contemplated, and if so, a proposed schedule for filing the parties' respective motion materials. b) whether any motion for a confidentaility order is contemplated, and if so, a proposed schedule for filing the parties respective motion materials. c)whether any motion pursuant to s.6(5)(a) or (b) of the PM(NOC) Regs. is contemplated, and if so, the timeframe for bringing such motion. d)a prposed schedule for further steps to be taken in this application, inlcuding whether the parties have agreed to a partial or full reversal of the order of filing evidence, and if not, whether any motion to that effect is contemplated, together with, as the case may be, a proposed schedule for filing the parties respective motion materials on such a motion. e) Both counsel's joint availabilities to participate in a case management telephone conference to discuss the proposals, issues or matters listed above. placed on file on 14-NOV-2011 Confirmed in writing to the party(ies)

Covering letter from Applicant dated 10-NOV-2011 concerning Doc. No. 15 placed on file on 10-NOV-2011

Solicitor's certificate of service on behalf of Tushar Tangri confirming service of Doc. 15 upon Respondent by personal service on 10-NOV-2011 filed on 10-NOV-2011

Motion Record containing the following original document(s): 11 12 13 14 Number of copies received: 3 on behalf of Applicant filed on 10-NOV-2011

Written Representations contained within a Motion Record on behalf of Applicant concerning Motion Doc. No. 11 filed on 10-NOV-2011

Affidavit of Marcail Delahunt sworn on 07-NOV-2011 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 11 with Exhibits A-D filed on 10-NOV-2011

Affidavit of Carrie Ku sworn on 10-NOV-2011 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 11 with Exhibits A-G filed on 10-NOV-2011

Notice of Motion contained within a Motion Record on behalf of Applicant returnable (but no hearing date indicated at this time) for an Order setting a schedule in this proceeding; a Protective Order. filed on 10-NOV-2011

Communication to the Court from the Registry dated 09-NOV-2011 re: Newly case managed NOC. Sent to Court for new schedule.

Proof of Service of Fax received from All parties with respect to Doc. #10 (Order from the Acting Chief Justice Noël dated October 17, 2011). placed on file on 18-OCT-2011

Order dated 17-OCT-2011 rendered by Acting Chief Justice S Noël Matter considered without personal appearance The Court's decision is with regard to Status Review Result: Pursuant to Rule 383 that Prothonotary Mireille Tabib is assigned as Case Management Judge in this matter. Filed on 18-OCT-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1137 page(s) 452 - 452 Interlocutory Decision

Affidavit of service of Susan Burkhardt sworn on 07-OCT-2011 on behalf of Applicant confirming service of the Notice of Application Doc. 1 upon Respondent the Minister of Health (served on Guy Maclean, Assistant to the director, Ottawa) by personal service on 06-OCT-2011 filed on 13-OCT-2011

Affidavit of service of Thilo Kierdorf sworn on 11-OCT-2011 on behalf of Applicant confirming service of the Notice of Applicaton Doc. 1 upon Respondent the Minister of Health (served on DOJ Toronto) by personal service on 07-OCT-2011 filed on 13-OCT-2011

Affidavit of service of Anite Kierdorf sworn on 11-OCT-2011 on behalf of Applicant confirming service of the Notice of Application Doc. 1 upon Respondent Apotex Inc. by personal service on 07-OCT-2011 filed on 13-OCT-2011

Covering letter from Respondent (Apotex) dated 11-OCT-2011 concerning Doc. Nos. 5 6 placed on file on 11-OCT-2011

Solicitor's certificate of service on behalf of Kevin Zive confirming service of document no. 5 upon all parties by telecopier on 11-OCT-2011 filed on 11-OCT-2011

Notice of appearance on behalf of Respondent (Apotex) filed on 11-OCT-2011

Affidavit of service of James Adney sworn on 11-OCT-2011 on behalf of Respondent (Min. of Health) confirming service of doc 3 upon all parties by telecopier on 11-OCT-2011 filed on 11-OCT-2011

Notice of appearance on behalf of Respondent (Min. of Health) filed on 11-OCT-2011

Service copy of Doc. No. 1 with proof of service upon Respondents on 07-OCT-2011 filed on 07-OCT-2011

Notice of application and 2 copies with regard to NOC filed on 06-OCT-2011 Certified copy(ies)/copy(ies) transmitted to Deputy Attorney General of Canada Tariff fee of $50.00 received: yes